Protalix BioTherapeutics Inc(PLX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PLX Protalix BioTherapeutics Inc

盘前交易 07-24 04:28:54 EDT

1.15

+0.04

+3.60%

最高1.17	最低1.11	成交量23.94万
今开1.11	昨收1.11	日振幅5.41%
总市值8,431万	流通市值6,270万	总股本7,332万
成交额27.27万	换手率0.44%	流通股本5,452万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PLX","market":"US","secType":"STK","nameCN":"Protalix BioTherapeutics Inc","latestPrice":1.15,"timestamp":1721764800000,"preClose":1.11,"halted":0,"volume":239384,"delay":0,"floatShares":54524042,"shares":73316084,"eps":0.065294,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.04,"latestTime":"07-24 04:28:54 EDT","open":1.11,"high":1.17,"low":1.11,"amount":272724.1587232,"amplitude":0.054054,"askPrice":1.35,"askSize":100,"bidPrice":0.9237,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.065294,"exchange":"AMEX","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721827800000},"adr":0,"listingDate":829022400000,"adjPreClose":1.15,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":1.15,"preClose":1.15,"latestTime":"18:23 EDT","volume":48,"amount":54.72,"timestamp":1721773428080},"volumeRatio":1.1862438067475791,"impliedVol":9.4482,"impliedVolPercentile":1},"requestUrl":"/m/hq/s/PLX","defaultTab":"news","newsList":[{"id":"2448480970","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 快速跳水5.36%报1.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448480970","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448480970?lang=zh_cn&edition=full","pubTime":"2024-07-04 00:25","pubTimestamp":1720023906,"startTime":"0","endTime":"0","summary":"北京时间2024年07月04日00时25分，Protalix Biotherapeutics, Inc. 股票出现异动，股价快速跳水5.36%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体跌幅为2.19%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704002506aef7cd96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704002506aef7cd96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2446825396","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 快速跳水5.04%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446825396","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446825396?lang=zh_cn&edition=full","pubTime":"2024-06-28 23:24","pubTimestamp":1719588263,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日23时24分，Protalix Biotherapeutics, Inc. 股票出现波动，股价快速跳水5.04%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Nutriband Inc C/Wts 、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Clearmind Medicine Inc.、Geovax Labs, Inc.、Carisma Therapeutics, Inc.较为活跃，换手率分别为2001.36%、695.20%、40.31%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nutriband Inc C/Wts ，振幅分别为106.78%、92.60%、74.65%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062823242396818099&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062823242396818099&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2446565401","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 下午盘股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446565401","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446565401?lang=zh_cn&edition=full","pubTime":"2024-06-28 01:15","pubTimestamp":1719508550,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日01时15分，Protalix Biotherapeutics, Inc. 股票出现异动，股价快速上涨5.28%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体跌幅为0.51%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.涨幅较大，Geovax Labs, Inc.、Kala Bio, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为2756.18%、376.14%、346.61%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.，振幅分别为322.04%、127.05%、81.43%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628011550aef6f441&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628011550aef6f441&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2446318068","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 急速拉升5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446318068","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446318068?lang=zh_cn&edition=full","pubTime":"2024-06-26 23:55","pubTimestamp":1719417349,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日23时55分，Protalix Biotherapeutics, Inc. 股票出现波动，股价急速上涨5.43%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体跌幅为1.18%。其相关个股中，Anew Medical, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Diamedica Therapeutics Inc.涨幅较大，Anew Medical, Inc.、Cns Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃，换手率分别为659.78%、145.72%、105.86%，振幅较大的相关个股有Anew Medical, Inc.、Effector Therapeutics Inc C/Wts 31/12/2025 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为112.12%、51.85%、45.14%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626235549941f16f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626235549941f16f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2445072024","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 快速上涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445072024","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445072024?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:39","pubTimestamp":1719236376,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时39分，Protalix Biotherapeutics, Inc. 股票出现异动，股价快速拉升5.13%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.83%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624213936941f0916&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624213936941f0916&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2442928878","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 急速上涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442928878","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442928878?lang=zh_cn&edition=full","pubTime":"2024-06-11 03:14","pubTimestamp":1718046889,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日03时14分，Protalix Biotherapeutics, Inc. 股票出现异动，股价急速拉升5.36%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Clene Inc C/Wts 30/12/2025 、Renovaro Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.、Hoth Therapeutics, Inc.较为活跃，换手率分别为66.01%、45.25%、41.94%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Seastar Medical Holding Corp C/Wts 28/10/2027 、Dermata Therapeutics Inc C/Wts ，振幅分别为142.25%、134.12%、108.54%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611031449af8cc709&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611031449af8cc709&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2441204608","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 下午盘大幅拉升5.31%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441204608","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441204608?lang=zh_cn&edition=full","pubTime":"2024-06-06 01:56","pubTimestamp":1717610217,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日01时56分，Protalix Biotherapeutics, Inc. 股票出现异动，股价大幅上涨5.31%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为1.26%。其相关个股中，Kineta, Inc.、Vigil Neuroscience, Inc.、Immatics N V C/Wts 01/07/2025 涨幅较大，Cns Pharmaceuticals, Inc.、Virios Therapeutics, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为146.52%、65.25%、52.10%，振幅较大的相关个股有Virios Therapeutics, Inc.、Kineta, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为66.83%、63.28%、54.10%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606015657941ec9ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606015657941ec9ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2439580202","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 临近收盘股价大跌5.69%报1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439580202","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439580202?lang=zh_cn&edition=full","pubTime":"2024-05-29 03:53","pubTimestamp":1716926020,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日03时53分，Protalix Biotherapeutics, Inc. 股票出现波动，股价大幅下挫5.69%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体跌幅为1.59%。其相关个股中，Insmed Incorporated、Calliditas Therapeutics Ab、Effector Therapeutics Inc C/Wts 31/12/2025 涨幅较大，Mustang Bio, Inc.、Exicure, Inc.、Kintara Therapeutics, Inc.较为活跃，换手率分别为94.08%、63.58%、47.50%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Exicure, Inc.、Biocardia Inc C/Wts 06/08/2024，振幅分别为89.11%、84.88%、52.98%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529035341968104cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529035341968104cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2437297929","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 大幅上涨6.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437297929","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437297929?lang=zh_cn&edition=full","pubTime":"2024-05-22 23:09","pubTimestamp":1716390591,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日23时09分，Protalix Biotherapeutics, Inc. 股票出现异动，股价快速上涨6.67%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.42%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522230951af89b0f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522230951af89b0f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2436878184","title":"Protalix Biotherapeutics, Inc. (De)2024财年第一财季实现净利润-4.60百万美元，同比减少46.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436878184","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436878184?lang=zh_cn&edition=full","pubTime":"2024-05-19 00:21","pubTimestamp":1716049273,"startTime":"0","endTime":"0","summary":"3月31日，Protalix Biotherapeutics, Inc. 公布财报，公告显示公司2024财年第一财季净利润为-4.60百万美元，同比减少46.96%；其中营业收入为3.75百万美元，同比减少60.90%，每股基本收益为-0.06美元。从资产负债表来看，Protalix Biotherapeutics, Inc. 总负债60.04百万美元，其中短期债务21.87百万美元，资产负债比为1.50，流动比率为1.38。机构评级：截至2024年3月31日，当前有1家机构对Protalix Biotherapeutics, Inc. 目标价做出预测，其中目标均价为14.00美元，其中最低目标价为14.00美元，最高目标价为14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405190021188b15edeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405190021188b15edeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX"],"gpt_icon":0},{"id":"2435303968","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 股价大涨5.45%报1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435303968","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435303968?lang=zh_cn&edition=full","pubTime":"2024-05-14 00:48","pubTimestamp":1715618919,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日00时48分，Protalix Biotherapeutics, Inc. 股票出现波动，股价快速拉升5.45%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为1.18%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051400483987e87921&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051400483987e87921&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2434851419","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 快速下跌16.80%报1.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434851419","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434851419?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:30","pubTimestamp":1715347804,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时30分，Protalix Biotherapeutics, Inc. 股票出现异动，股价大幅下挫16.80%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.97%。其相关个股中，Transcode Therapeutics, Inc.、Ventyx Biosciences, Inc.、Onconetix, Inc.涨幅较大，诺瓦瓦克斯医药、Allarity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为26.15%、16.12%、6.19%，振幅较大的相关个股有Zymeworks Inc.、Zyversa Therapeutics, Inc.、Zevra Therapeutics, Inc.，振幅分别为0.00%、0.00%、0.00%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051021300587e87182&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051021300587e87182&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2434732012","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 急速上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434732012","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434732012?lang=zh_cn&edition=full","pubTime":"2024-05-10 00:06","pubTimestamp":1715270760,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日00时06分，Protalix Biotherapeutics, Inc. 股票出现异动，股价快速上涨5.26%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Seres Therapeutics, Inc.、G1 Therapeutics, Inc.、Notable Labs, Ltd.涨幅较大，Notable Labs, Ltd.、Allarity Therapeutics, Inc.、G1 Therapeutics, Inc.较为活跃，换手率分别为155.47%、151.23%、49.55%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Notable Labs, Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为58.46%、57.24%、50.09%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051000060187e86d1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051000060187e86d1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2433640861","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 股价大跌5.26%报1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433640861","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433640861?lang=zh_cn&edition=full","pubTime":"2024-05-06 22:51","pubTimestamp":1715007065,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日22时51分，Protalix Biotherapeutics, Inc. 股票出现异动，股价大幅下挫5.26%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Jasper Therapeutics Inc C/Wts 24/09/2026 、Nrx Pharmaceuticals, Inc.、Tc Biopharm  Plc涨幅较大，Tc Biopharm  Plc、Allarity Therapeutics, Inc.、Lyra Therapeutics, Inc.较为活跃，换手率分别为1086.51%、712.48%、66.62%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Tc Biopharm  Plc、Nrx Pharmaceuticals, Inc.，振幅分别为95.51%、84.25%、40.00%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506225105861eb360&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506225105861eb360&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2432688089","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 大幅拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432688089","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432688089?lang=zh_cn&edition=full","pubTime":"2024-05-02 00:22","pubTimestamp":1714580553,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日00时22分，Protalix Biotherapeutics, Inc. 股票出现异动，股价急速上涨5.26%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为1.01%。其相关个股中，Cytomx Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Cyclacel Pharmaceuticals, Inc.涨幅较大，Palisade Bio, Inc.、Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1328.05%、213.46%、156.54%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为188.34%、77.43%、66.20%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502002233861ea8e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502002233861ea8e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2431458892","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 大幅上涨5.22%报1.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431458892","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431458892?lang=zh_cn&edition=full","pubTime":"2024-04-30 00:11","pubTimestamp":1714407098,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日00时11分，Protalix Biotherapeutics, Inc. 股票出现波动，股价快速上涨5.22%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Calidi Biotherapeutics, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028、Zura Bio Limited C/Wts 涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Annovis Bio, Inc.较为活跃，换手率分别为962.99%、50.59%、43.53%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Annovis Bio, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为98.32%、79.12%、75.06%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240430001138861ea233&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240430001138861ea233&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2430204916","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 早盘股价大跌5.93%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430204916","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430204916?lang=zh_cn&edition=full","pubTime":"2024-04-26 23:25","pubTimestamp":1714145142,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日23时25分，Protalix Biotherapeutics, Inc. 股票出现异动，股价大幅下挫5.93%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Biodexa Pharmaceuticals Plc、Cassava Sciences Inc C/Wts 15/11/2024、Zura Bio Limited C/Wts 涨幅较大，Biodexa Pharmaceuticals Plc、Kintara Therapeutics, Inc.、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为1242.02%、107.92%、42.94%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Biodexa Pharmaceuticals Plc、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为81.90%、73.12%、66.85%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042623254287e843d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042623254287e843d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2429143128","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 下午盘快速拉升5.08%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429143128","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429143128?lang=zh_cn&edition=full","pubTime":"2024-04-24 01:41","pubTimestamp":1713894113,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日01时41分，Protalix Biotherapeutics, Inc. 股票出现异动，股价大幅拉升5.08%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为1.61%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240141537922b755&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240141537922b755&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2428491975","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428491975","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428491975?lang=zh_cn&edition=full","pubTime":"2024-04-19 03:29","pubTimestamp":1713468566,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日03时29分，Protalix Biotherapeutics, Inc. 股票出现异动，股价大幅下跌5.22%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体跌幅为0.65%。其相关个股中，Artelo Biosciences Inc C/Wts 20/06/2024 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Clene Inc C/Wts 30/12/2025 涨幅较大，Bio-Path Holdings, Inc.、Benitec Biopharma Inc.、Soligenix, Inc.较为活跃，换手率分别为10779.25%、113.70%、53.56%，振幅较大的相关个股有Bio-Path Holdings, Inc.、Artelo Biosciences Inc C/Wts 20/06/2024 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为126.85%、75.31%、73.93%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190329267a53d1e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190329267a53d1e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2428349774","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 早盘股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428349774","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428349774?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:55","pubTimestamp":1713362151,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时55分，Protalix Biotherapeutics, Inc. 股票出现异动，股价急速上涨5.23%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.80%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417215551861e6b8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417215551861e6b8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.protalix.com","stockEarnings":[{"period":"1week","weight":-0.0171},{"period":"1month","weight":-0.0171},{"period":"3month","weight":-0.0496},{"period":"6month","weight":-0.2384},{"period":"1year","weight":-0.2857},{"period":"ytd","weight":-0.3539}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.017},{"period":"3month","weight":0.0957},{"period":"6month","weight":0.1347},{"period":"1year","weight":0.2192},{"period":"ytd","weight":0.1651}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Protalix Biotherapeutics, Inc.最初于1992年4月在佛罗里达州注册成立，并于2016年3月在特拉华州重新注册成立。该公司是一家生物制药公司，专注于开发、生产和商业化由专有的ProCellEx植物细胞蛋白表达系统生产的重组治疗蛋白。该公司是第一家也是唯一一家获得FDA批准的通过植物细胞表达悬浮蛋白生产的公司。该公司独特的表达系统代表了一种以工业规模开发重组蛋白的新方法。该公司的战略重点是开发主要通过ProCellEx生产的定制复杂重组治疗性蛋白质，同时在生产前和生产后对蛋白质进行基因工程和化学修饰。该公司打算通过改进治疗蛋白的生物学特性（例如，糖基化、半衰期、免疫原性），进行此类工程设计和修改，以提供额外的临床益处。","yearOnYearQuotes":[{"month":1,"riseRate":0.705882,"avgChangeRate":0.101027},{"month":2,"riseRate":0.411765,"avgChangeRate":0.04937},{"month":3,"riseRate":0.294118,"avgChangeRate":-0.041326},{"month":4,"riseRate":0.555556,"avgChangeRate":0.048495},{"month":5,"riseRate":0.222222,"avgChangeRate":-0.026617},{"month":6,"riseRate":0.444444,"avgChangeRate":-0.034136},{"month":7,"riseRate":0.388889,"avgChangeRate":-0.044291},{"month":8,"riseRate":0.352941,"avgChangeRate":-0.009879},{"month":9,"riseRate":0.352941,"avgChangeRate":0.026985},{"month":10,"riseRate":0.352941,"avgChangeRate":-0.071025},{"month":11,"riseRate":0.352941,"avgChangeRate":-0.022185},{"month":12,"riseRate":0.352941,"avgChangeRate":-0.0158}],"exchange":"AMEX","name":"Protalix BioTherapeutics Inc","nameEN":"Protalix BioTherapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Protalix BioTherapeutics Inc(PLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Protalix BioTherapeutics Inc(PLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Protalix BioTherapeutics Inc,PLX,Protalix BioTherapeutics Inc股票,Protalix BioTherapeutics Inc股票老虎,Protalix BioTherapeutics Inc股票老虎国际,Protalix BioTherapeutics Inc行情,Protalix BioTherapeutics Inc股票行情,Protalix BioTherapeutics Inc股价,Protalix BioTherapeutics Inc股市,Protalix BioTherapeutics Inc股票价格,Protalix BioTherapeutics Inc股票交易,Protalix BioTherapeutics Inc股票购买,Protalix BioTherapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Protalix BioTherapeutics Inc(PLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Protalix BioTherapeutics Inc(PLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}